» Articles » PMID: 22017292

Renal Histological Lesions and Outcome in Liver Transplant Recipients

Overview
Journal Clin Transplant
Specialty General Surgery
Date 2011 Oct 25
PMID 22017292
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic kidney disease in liver transplant (OLT) recipients is often attributed to calcineurin inhibitors (CNI) toxicity, but little is known about the spectrum of their renal histological lesions.

Methods: Between 1988 and 2008, 1698 OLTs were performed in our center. We retrospectively analyzed clinical and histological data on 23 recipients (1.4%) referred for kidney biopsy (KB).

Results: Median age at OLT was 50.2 yr, 65.2% were men, 30.4% had hepatitis C, and 95.7% were given CNI. KB was performed 6.9 yr (median) post-OLT. Median creatinine was 1 mg/dL pre-OLT and 2.2 mg/dL at KB. Main pathological diagnoses were focal segmental and global glomerulosclerosis (n = 8, 34.8%), glomerular diseases (7, 30.4%), CNI toxicity (2, 8.7%), and diabetic nephropathy (2, 8.7%). Moderate/severe interstitial fibrosis, tubular atrophy, arteriosclerosis, and hyalinosis were present in 47.8%, 43.5%, 60.9%, and 56.5%, respectively. Twelve patients (52.5%) reached end-stage renal disease (ESRD) and 17 (73.9%) died. Death was more common among those reaching ESRD, but the difference was not significant (83.3% vs. 63.6%, p = 0.37).

Conclusion: Renal histology is variable and not limited to CNI toxicity in OLT recipients referred for KB. Whether management based on KB findings can directly improve outcomes remains unclear.

Citing Articles

The Renal Histological Correlates of Refractory Renal Dysfunction After Liver Transplantation.

Choudhary N, Dhampalwar S, Saraf N, Bansal S, Gadde A, Rastogi A J Clin Exp Hepatol. 2023; 13(4):586-591.

PMID: 37440946 PMC: 10333932. DOI: 10.1016/j.jceh.2023.01.010.


Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.

Frost K, Jilek J, Sinari S, Klein R, Billheimer D, Wright S Drug Metab Dispos. 2022; 51(2):155-164.

PMID: 36328481 PMC: 9900843. DOI: 10.1124/dmd.122.001038.


Clinical Relevance of Kidney Biopsy in Patients Qualified for Liver Transplantation and After This Procedure in the Model for End-stage Liver Disease (MELD) Era: Where Are We Today?.

Wieliczko M, Oldakowska-Jedynak U, Malyszko J Ann Transplant. 2020; 25:e925891.

PMID: 33077702 PMC: 7587156. DOI: 10.12659/AOT.925891.


Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.

Lee J, Cho Y, Ryu S, Kim S, Lee Y, Jang I Kidney Res Clin Pract. 2016; 32(4):153-7.

PMID: 26877934 PMC: 4714096. DOI: 10.1016/j.krcp.2013.08.002.


Hidden pathology of kidney disease after liver transplantation.

Kim Y Kidney Res Clin Pract. 2016; 32(4):145-6.

PMID: 26877932 PMC: 4714186. DOI: 10.1016/j.krcp.2013.10.003.